NHS National Pharmaceuticals Dasatinib and Paliperidone Injection
This is a contract result notice, not an open opportunity. Details from the official award data.
Proposed framework agreement for NHS National Generic Pharmaceuticals Dasatinib and Paliperidone Injection.
Offer reference number: CM/PHG/22/5694<br/><br/><br/>Potential periods of call-offs under the framework agreement:<br/>CM/PHG/22/5694/00 - Dasatinib <br/>CESW 01/05/2023 – 30/04/2024 – (12 Months) <br/>LSNE 01/05/2023 – 30/04/2024 – (12 Months)<br/>NWLN 01/05/2023 – 30/04/2024 – (12 Months)<br/><br/>CM/PHG/22/5694/01 - Paliperidone Injection: <br/>LSNE 01/05/2023 – 31/05/2024 (13 Months) <br/>NWLN 01/05/2023 – 31/01/2025 (21 months)
What this notice demands of you
1 named, none in explicit obligation language. Each one is quoted from the notice.
Proposed framework agreement for NHS National Generic Pharmaceuticals Dasatinib and Paliperidone Injection.
Matched against the notice text, so this is a floor — the tender pack will demand things the notice never mentions. “Says must” means the quoted sentence itself used obligation language; anything ambiguous is left as a mention.
Make the case to bid
Reveal who to approach at NHS England, and generate a go-to-market strategy from their news, accounts and people.
Free to start. Named contacts come from published notices; the strategy is generated from the buyer’s news, accounts and people.
- OCID
- ocds-h6vhtk-03981f
- Stage
- award · Awarded
- Source
- Find a Tender
- Buyer ref
- 012161-2023
Contains public sector information licensed under the Open Government Licence v3.0. Source data © Crown copyright.
Who wins this kind of work
The suppliers and buyers around this opportunity — drawn from official award data. Drag to orbit; click a node to explore.
Top suppliers & buyers in Medical Equipment & Pharmaceuticals
NHS England’s tender network